US FDA Vaccines Adcomm May Be Called To Review COVID-19 Vaccine Strain Changes

 
• By Derrick Gingery
  
CBER's Peter Marks is interviewed in his basement for the FDA/CMS Summit 2020. (screenshot)
Peter Marks said that the source of anaphylactic reactions to the vaccines still is unknown, but studies are ongoing. • Source: screenshot
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Vaccines

More from Pink Sheet